Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Alter BP, Baerlocher GM, Savage SA et al: Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007; 110: 1439–1447.
Bessler M, Wilson BD, Mason PJ : Dyskeratosis congenita. FEBS Letts 2010; 584: 3831–3838.
Calado RT, Young NS : Telomere Diseases. N Engl J Med 2009; 361: 2353–2365.
Dokal I : Dyskeratosis Congenita. Hematol Am Soc Hematol Edu Program 2011; 2011: 480–486.
Du HY, Pumbo E, Ivanovich J et al: TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 2009; 113: 309–316.
Fogarty PF, Yamaguchi H, Wiestner A et al: Late presentation of dyskeratosis congenita as apparently acquired aplstic anaemia due to mutations in telomerase RNA. Lancet 2003; 362: 1628–1630.
Gramatges MM, Bertuch AA : Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res 2013; 162: 353–363.
Savage SA, Dokal I, Armanios M et al: Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer 2009; 53: 520–523.
Vulliamy TJ, Knight SW, Mason PJ, Dokal I : Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol Dis 2001; 27: 3 53–77.
Vulliamy TJ, Marrone M, Knight S, Walne A, Mason PJ, Dokal I : Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood 2006; 107: 2680–2685.
Walne AJ, Dokal I : Advances in the understanding of Dyskeratosis Congenita. Br J Haematol 2009; 145: 164–172.
Acknowledgements
This work was supported by EuroGentest, an EU-FP6 supported NoE, contract number 512148 (EuroGentest Unit 3: ‘Clinical genetics, community genetics and public health’, Workpackage 3.2).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Dokal, I., Vulliamy, T., Mason, P. et al. Clinical utility gene card for: Dyskeratosis congenita – update 2015. Eur J Hum Genet 23, 558 (2015). https://doi.org/10.1038/ejhg.2014.170
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2014.170
This article is cited by
-
Dyskeratosis congenita associated with a novel missense variant in TERT: Approach for the dermatologists
Archives of Dermatological Research (2024)
-
The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia
Virchows Archiv (2023)
-
Boosting NAD ameliorates hematopoietic impairment linked to short telomeres in vivo
GeroScience (2023)
-
Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1
Stem Cell Research & Therapy (2021)
-
Telomere biology disorders
npj Genomic Medicine (2021)
